Logo image of LION

LIONSGATE STUDIOS CORP (LION) Stock Fundamental Analysis

NYSE:LION - New York Stock Exchange, Inc. - CA53626N1024 - Common Stock - Currency: USD

6.15  -0.18 (-2.84%)

After market: 6.0801 -0.07 (-1.14%)

Fundamental Rating

2

Taking everything into account, LION scores 2 out of 10 in our fundamental rating. LION was compared to 73 industry peers in the Entertainment industry. Both the profitability and financial health of LION have multiple concerns. LION has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

LION had negative earnings in the past year.
LION had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: LION reported negative net income in multiple years.
In the past 5 years LION always reported negative operating cash flow.
LION Yearly Net Income VS EBIT VS OCF VS FCFLION Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

LION has a Return On Assets (-2.70%) which is in line with its industry peers.
The Return On Invested Capital of LION (4.15%) is better than 71.23% of its industry peers.
Industry RankSector Rank
ROA -2.7%
ROE N/A
ROIC 4.15%
ROA(3y)1.47%
ROA(5y)N/A
ROE(3y)-6.56%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LION Yearly ROA, ROE, ROICLION Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -5 -10 -15 -20

1.3 Margins

LION has a better Operating Margin (5.41%) than 71.23% of its industry peers.
With an excellent Gross Margin value of 117.71%, LION belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
OM 5.41%
PM (TTM) N/A
GM 117.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LION Yearly Profit, Operating, Gross MarginsLION Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

More info and screens

0

2. Health

2.1 Basic Checks

There is no outstanding debt for LION. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LION Yearly Shares OutstandingLION Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M
LION Yearly Total Debt VS Total AssetsLION Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

LION has an Altman-Z score of -0.20. This is a bad value and indicates that LION is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of LION (-0.20) is worse than 67.12% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.2
ROIC/WACCN/A
WACCN/A
LION Yearly LT Debt VS Equity VS FCFLION Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

LION has a Current Ratio of 0.36. This is a bad value and indicates that LION is not financially healthy enough and could expect problems in meeting its short term obligations.
LION has a worse Current ratio (0.36) than 84.93% of its industry peers.
A Quick Ratio of 0.36 indicates that LION may have some problems paying its short term obligations.
LION's Quick ratio of 0.36 is on the low side compared to the rest of the industry. LION is outperformed by 83.56% of its industry peers.
Industry RankSector Rank
Current Ratio 0.36
Quick Ratio 0.36
LION Yearly Current Assets VS Current LiabilitesLION Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 200M 400M 600M

More info and screens

2

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3100%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-10.62%

3.2 Future

LION is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 51.27% yearly.
LION is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.43% yearly.
EPS Next Y108.82%
EPS Next 2Y97.21%
EPS Next 3Y51.27%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y3.83%
Revenue Next 3Y4.43%
Revenue Next 5YN/A

3.3 Evolution

LION Yearly Revenue VS EstimatesLION Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2025 2026 2027 2028 1B 2B 3B
LION Yearly EPS VS EstimatesLION Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 0 0.1 0.2 0.3 0.4

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

LION reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 14.38, the valuation of LION can be described as correct.
LION's Price/Forward Earnings ratio is rather cheap when compared to the industry. LION is cheaper than 83.56% of the companies in the same industry.
LION is valuated cheaply when we compare the Price/Forward Earnings ratio to 33.87, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 14.38
LION Price Earnings VS Forward Price EarningsLION Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150 200

4.2 Price Multiples

LION's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. LION is cheaper than 90.41% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.71
LION Per share dataLION EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10 -15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LION's earnings are expected to grow with 51.27% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y97.21%
EPS Next 3Y51.27%

More info and screens

0

5. Dividend

5.1 Amount

LION does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LIONSGATE STUDIOS CORP

NYSE:LION (8/11/2025, 8:04:00 PM)

After market: 6.0801 -0.07 (-1.14%)

6.15

-0.18 (-2.84%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-05 2025-11-05
Inst Owners34.58%
Inst Owner Change170.35%
Ins Owners3.74%
Ins Owner Change-1802.63%
Market Cap1.76B
Analysts78.57
Price Target8.99 (46.18%)
Short Float %N/A
Short Ratio3.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)303.17%
Min EPS beat(2)-20.6%
Max EPS beat(2)626.95%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.83%
Min Revenue beat(2)0.44%
Max Revenue beat(2)3.22%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.08%
PT rev (3m)-27.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.95%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.38
P/S 0.83
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 3.71
EPS(TTM)-0.2
EYN/A
EPS(NY)0.43
Fwd EY6.96%
FCF(TTM)-1.3
FCFYN/A
OCF(TTM)-1.27
OCFYN/A
SpS7.44
BVpS-3.78
TBVpS-15.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.7%
ROE N/A
ROCE 5.25%
ROIC 4.15%
ROICexc 4.53%
ROICexgc N/A
OM 5.41%
PM (TTM) N/A
GM 117.71%
FCFM N/A
ROA(3y)1.47%
ROA(5y)N/A
ROE(3y)-6.56%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 1.48
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.36
Quick Ratio 0.36
Altman-Z -0.2
F-Score1
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)0.51%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3100%
EPS Next Y108.82%
EPS Next 2Y97.21%
EPS Next 3Y51.27%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-10.62%
Revenue Next Year0%
Revenue Next 2Y3.83%
Revenue Next 3Y4.43%
Revenue Next 5YN/A
EBIT growth 1Y331.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1414.8%
EBIT Next 3Y154.59%
EBIT Next 5Y102.23%
FCF growth 1Y-72843.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-70899.5%
OCF growth 3YN/A
OCF growth 5YN/A